LZTS1 and lung carcinoma: Moreover, Ching-Wen Lin et al. reported that miR-135b targets LZTS1 and negative regulators of the Hippo pathway, including LATS2, NDR2, MOB1, and β-TrCP, leading to lung cancer metastasis25.